谷歌浏览器插件
订阅小程序
在清言上使用

Pathological Complete Response to Long-Course Neoadjuvant Alectinib in Lung Adenocarcinoma with EML4-ALK Rearrangement: Report of Two Cases and Systematic Review of Case Reports

Frontiers in Oncology(2023)

引用 1|浏览23
关键词
lung adenocarcinoma,ALK rearrangement,neoadjuvant therapy,alectinib,pathological complete response
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要